SIGA Technologies
SIGA Technologies Logo
About SIGA Technologies
SIGA Technologies Inc is a commercial-stage pharmaceutical company specializing in the development and commercialization of antiviral treatments for smallpox and other orthopoxvirus infections. Its lead product, TPOXX (tecovirimat), is an FDA-approved antiviral drug for the treatment of smallpox and is also approved in other regions for the treatment of orthopoxvirus infections, including mpox, cowpox, and vaccinia complications. SIGA collaborates with governments and organizations worldwide to enhance global health security and preparedness against infectious disease outbreaks.
Address
31 East 62nd Street,
New York, 10065
United States
Year founded
1995
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Report inaccurate data
Request an update to help us keep the brand up-to-date.
